Search results
Kura Oncology (NASDAQ:KURA) Stock Rating Reaffirmed by HC Wainwright
ETF DAILY NEWS· 6 days agoKura Oncology (NASDAQ:KURA – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a research note issued on Monday, Benzinga reports. HC Wainwright ...
CAR-T Plus Stem-Cell Transplant Promising for CD7+ Blood Cancers
MedPage Today· 6 days agoA strategy of sequential CD7 chimeric antigen receptor (CAR) T-cell therapy and haploidentical...
Study reveals insights into DDX41 protein's role in blood cancer pathogenesis
Medical Xpress· 7 days agoA study led by Professors Hongtae Kim and JaYil Lee from the Department of Biological Sciences, in collaboration with researchers from the Catholic University of Korea, sheds light on the pivotal ...
Deverra Therapeutics Granted FDA Fast Track Designation for DVX101
Digital Journal· 5 days agoDesignation Validates Preliminary Data and Supports Accelerated Drug Development SEATTLE, WA / ACCESSWIRE / April 24, 2024 / Deverra Therapeutics, Inc., a clinical-stage biotechnology company ...
Coffee Memorial Blood Center seeks platelet donations amid low supply
KAMR Amarillo· 7 days agoOfficials with the Coffee Memorial Blood Center asked community members to donate blood platelets...
MD Anderson Research Highlights for April 24, 2024
Newswise· 6 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These adva
Arthritis linked to blood cancer mutations
Medical Xpress· 7 days agoThe research focused on seronegative rheumatoid arthritis, a sub-type of the more common rheumatoid arthritis (RA), that differs in the inconsistency of...
ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest...
KTLA-TV Los Angeles· 5 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results ...
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Investor's Business Daily· 5 days agoThat could be why the first generation of radiopharmaceuticals were flops, Seth, the Actinium CEO,...
Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition
Investing.com· 1 day agoThe earnings call also marked a significant leadership transition, with CEO Rick Gonzalez announcing...